Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Nicoll

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
BMC Gastroenterology|July 12, 2022
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-upPaul J Clark, Patricia C Valery, James Ward, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 15, 2021
Management, outcomes and survival of an Australian IgG4-SC cohort: The MOSAIC studyWilliam Kemp, Ammar Majeed, Joanne Mitchell, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 21, 2017
Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard TherapyStuart K Roberts, Ricky Lim, Simone Strasser, et al.
NEJM Evidence|January 28, 2025
Larsucosterol for the Treatment of Alcohol-Associated HepatitisMitchell Shiffman, Ben Da, Aparna Goel, et al.
Hepatology International|August 25, 2022
Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort studyKurvi Patwala, David Stephen Prince, Yael Celermajer, et al.
Cancers|December 23, 2023
Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie Ngu, et al.
Cancers|June 19, 2024
Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
Cancers|September 14, 2024
Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
BMC Cancer|July 7, 2024
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)Alan Wigg, Jonathan Tibballs, Richard Woodman, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
BMC Gastroenterology|July 12, 2022
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-upPaul J Clark, Patricia C Valery, James Ward, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 15, 2021
Management, outcomes and survival of an Australian IgG4-SC cohort: The MOSAIC studyWilliam Kemp, Ammar Majeed, Joanne Mitchell, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 21, 2017
Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard TherapyStuart K Roberts, Ricky Lim, Simone Strasser, et al.
NEJM Evidence|January 28, 2025
Larsucosterol for the Treatment of Alcohol-Associated HepatitisMitchell Shiffman, Ben Da, Aparna Goel, et al.
Hepatology International|August 25, 2022
Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort studyKurvi Patwala, David Stephen Prince, Yael Celermajer, et al.
Cancers|December 23, 2023
Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie Ngu, et al.
Cancers|June 19, 2024
Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
Cancers|September 14, 2024
Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
BMC Cancer|July 7, 2024
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)Alan Wigg, Jonathan Tibballs, Richard Woodman, et al.
Pageof 6